Related Experiment Video
Updated: May 7, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma
Yeonhong Do1, Young Hyeon Ahn2, Young Chang1
1Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
A higher number of cardiometabolic risk factors (CMRFs) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)-related liver cancer predicts worse survival. This cumulative metabolic burden is linked to larger tumors and elevated PIVKA-II levels.
Area of Science:
- Hepatology
- Oncology
- Cardiology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasing cause of hepatocellular carcinoma (HCC).
- The impact of cumulative cardiometabolic risk factor (CMRF) burden on MASLD-related HCC prognosis is not well understood.
Purpose of the Study:
- To investigate the prognostic implications of cumulative CMRF burden in patients with MASLD-related HCC.
- To assess the association between CMRF count and overall survival (OS) and recurrence-free survival (RFS).
Main Methods:
- Retrospective cohort study of 94 patients with MASLD-related HCC.
- Calculation of a modified CMRF count based on eight variables.
- Stratification of patients by CMRF count (<5 or ≥5) and survival analysis using Kaplan-Meier and Cox regression.
Main Results:
- Higher CMRF burden correlated with older age, larger tumor diameter, and elevated PIVKA-II.
- Patients with CMRF count ≥5 exhibited significantly worse OS and RFS.
- Hypertension was an independent predictor of poor OS, while diabetes lost significance after adjustment.
Conclusions:
- Cumulative metabolic burden, quantified by CMRF count, is associated with larger tumors and poorer survival in MASLD-related HCC.
- A higher CMRF burden is a significant prognostic indicator for patients with MASLD-related HCC.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cardiomyopathy IV: Restrictive Cardiomyopathy